Tag: heart failure

Bayer announces start of Phase 2 GenePHIT trial for AB-1002

businessnewstoday- February 17, 2024

Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization ... Read More

Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets

businessnewstoday- December 2, 2023

Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States Food and Drug Administration (FDA) for its ... Read More

WhiteSwell’s eLym System shows promise in acute decompensated heart failure treatment

businessnewstoday- October 8, 2023

WhiteSwell, a frontrunner in the treatment of acute decompensated heart failure (ADHF), has shared optimistic initial results from its continuing DELTA-HF trial centered around the ... Read More

American Regent’s HEART-FID trial for INJECTAFER fails to meet primary endpoint

businessnewstoday- August 27, 2023

American Regent, Inc., a subsidiary of Daiichi Sankyo Group, has announced disappointing results from its phase 3 HEART-FID trial of INJECTAFER (ferric carboxymaltose injection) for ... Read More

China’s NMPA expands AstraZeneca’s Forxiga use as heart failure treatment

businessnewstoday- August 20, 2023

China's National Medical Products Administration (NMPA) has approved AstraZeneca's Forxiga (dapagliflozin) for diminishing the risk of cardiovascular fatalities and hospitalizations in adults diagnosed with symptomatic ... Read More

Lupin Digital Health unveils Lyfe Digital Heart Failure Clinic

businessnewstoday- August 7, 2023

Indian cardiac digital therapeutics entity, Lupin Digital Health (LDH), marked another achievement with the unveiling of its Lyfe Digital Heart Failure Clinic. Designed to cater ... Read More

BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India

businessnewstoday- July 26, 2023

BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard ... Read More

Viz.ai, Bristol Myers Squibb sign deal for AI algorithm and Viz HCM software

businessnewstoday- March 4, 2023

Viz.ai, an artificial intelligence (AI) powered health technology company, has signed a multi-year agreement with Bristol Myers Squibb (BMY) to provide the latter with an ... Read More

Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India

businessnewstoday- January 17, 2023

Glenmark Pharmaceuticals said that it has rolled out the sacubitril + valsartan tablets for the treatment of heart failure in India under the brand name ... Read More

Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn

Raghuram Kadari- November 2, 2022

Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash deal valued at approximately $16.6 billion. The ... Read More